Effect of oral glucose loading on plasma insulin, potassium, renin and aldosterone in normal subjects and patients with primary hyperaldosteronism. 1982

C Beretta-Piccoli, and P Weidmann, and M G Bianchetti, and J J Brown, and R Fraser, and A F Lever, and L Link, and J I Robertson

The effects of standard oral glucose loading (100 g) on plasma aldosterone and some regulatory factors were assessed in patients with primary hyperaldosteronism and normal subjects. Following overnight fast, mean plasma glucose was identical (10 patients and normal subjects approximately matched per age and sex); plasma insulin, potassium and renin levels were lower and plasma aldosterone higher in the patients. Glucose loading significantly increased plasma glucose and insulin concentrations and decreased plasma potassium and aldosterone levels in both groups; plasma renin activity was significantly increased only in normal subjects. The increases in plasma insulin and the decreases in plasma potassium or aldosterone tended to be blunted in primary hyperaldosteronism. Relationships among glucose-induced changes in plasma aldosterone and other factors were assessed by multiple regression analysis in these patients and normal subjects as well as an additional group of 21 normal subjects; in the latter, plasma cortisol was also measured and found to decrease significantly after glucose loading. Changes in plasma aldosterone correlated (P less than 0.025) more closely with those in plasma potassium in the patients and with variations in plasma renin activity in the normal subjects. These findings suggest that complex metabolic changes occur following glucose ingestion which are capable of modifying aldosterone secretion in normal subjects and primary hyperaldosteronism. The aldosterone-inhibitory effect of glucose tends to be blunted in the latter disorder. This could be related at least in part to an impaired insulin response in primary hyperaldosteronism.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006929 Hyperaldosteronism A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA. Aldosteronism,Conn Syndrome,Conn's Syndrome,Primary Hyperaldosteronism,Conns Syndrome,Hyperaldosteronism, Primary,Syndrome, Conn,Syndrome, Conn's

Related Publications

C Beretta-Piccoli, and P Weidmann, and M G Bianchetti, and J J Brown, and R Fraser, and A F Lever, and L Link, and J I Robertson
April 1977, Endocrinology,
C Beretta-Piccoli, and P Weidmann, and M G Bianchetti, and J J Brown, and R Fraser, and A F Lever, and L Link, and J I Robertson
July 1978, The Journal of clinical endocrinology and metabolism,
C Beretta-Piccoli, and P Weidmann, and M G Bianchetti, and J J Brown, and R Fraser, and A F Lever, and L Link, and J I Robertson
May 1980, Clinical pharmacology and therapeutics,
C Beretta-Piccoli, and P Weidmann, and M G Bianchetti, and J J Brown, and R Fraser, and A F Lever, and L Link, and J I Robertson
May 1968, Pathologie et biologie,
C Beretta-Piccoli, and P Weidmann, and M G Bianchetti, and J J Brown, and R Fraser, and A F Lever, and L Link, and J I Robertson
April 1969, The Journal of clinical endocrinology and metabolism,
C Beretta-Piccoli, and P Weidmann, and M G Bianchetti, and J J Brown, and R Fraser, and A F Lever, and L Link, and J I Robertson
July 1968, The Journal of clinical endocrinology and metabolism,
C Beretta-Piccoli, and P Weidmann, and M G Bianchetti, and J J Brown, and R Fraser, and A F Lever, and L Link, and J I Robertson
June 2005, European journal of nutrition,
C Beretta-Piccoli, and P Weidmann, and M G Bianchetti, and J J Brown, and R Fraser, and A F Lever, and L Link, and J I Robertson
January 1992, Renal failure,
C Beretta-Piccoli, and P Weidmann, and M G Bianchetti, and J J Brown, and R Fraser, and A F Lever, and L Link, and J I Robertson
March 1979, Kidney international,
C Beretta-Piccoli, and P Weidmann, and M G Bianchetti, and J J Brown, and R Fraser, and A F Lever, and L Link, and J I Robertson
July 1958, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!